| Seronica Renee Bradley, LPN | |
|
11440 Van Wyck Expy, South Ozone Park, NY 11420-2229 | |
| (718) 322-3455 | |
| (718) 848-4152 |
| Full Name | Seronica Renee Bradley |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 11440 Van Wyck Expy, South Ozone Park, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306350574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 308639-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Seronica Renee Bradley, LPN 11440 Van Wyck Expy, South Ozone Park, NY 11420-2229 Ph: (718) 322-3455 | Seronica Renee Bradley, LPN 11440 Van Wyck Expy, South Ozone Park, NY 11420-2229 Ph: (718) 322-3455 |
News Archive
In the first national study of its kind, a UC Irvine sociologist finds that black immigrants who arrive in America from black-majority regions of the world are healthier than those from white-majority regions
A team of scientists from the USA and Canada recently characterized the cross-neutralizing potency of anti-SARS-CoV-2 antibodies isolated from COVID-19 patients. The findings reveal that some of the isolated antibodies targeting the spike RBD and the S2 subunit are capable of cross-neutralizing other members of the human beta-coronavirus family.
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced the initiation of a dose escalation study with its oncology drug candidate tamibarotene combined with TRISENOX® (arsenic trioxide) injection (marketed by Cephalon, Inc.) in patients with relapsed acute promyelocytic leukemia (APL).
As nocturnal animals, bats rely echolocation to navigate and hunt prey. By bouncing sound waves off objects, including the bugs that are their main diet, bats can produce an accurate representation of their environment in total darkness. Now, researchers at the University of Southern Denmark and the University of Pennsylvania have shown that this amazing ability is enabled by a physical trait never before seen in mammals: so-called "superfast" muscles.
› Verified 1 days ago
Jennifer Tomlinson, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 11440 Van Wyck Expy, South Ozone Park, NY 11420 Phone: 718-322-3455 Fax: 718-848-4152 |